Vaxcyte, Inc. (PCVX)
USD 32.5
(2.85%)
USD 32.5
(2.85%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -402.26 Million USD | -67.86% |
| 2022 | -239.64 Million USD | -139.44% |
| 2021 | -100.08 Million USD | -13.97% |
| 2020 | -87.81 Million USD | -64.15% |
| 2019 | -53.49 Million USD | -81.44% |
| 2018 | -29.48 Million USD | -71.05% |
| 2017 | -17.23 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -103.12 Million USD | 19.87% |
| 2024 Q2 | -128.7 Million USD | -35.45% |
| 2024 Q1 | -95.02 Million USD | 47.44% |
| 2023 Q3 | -92.66 Million USD | -35.59% |
| 2023 Q2 | -68.33 Million USD | -41.31% |
| 2023 FY | -402.26 Million USD | -67.86% |
| 2023 Q1 | -48.36 Million USD | 48.25% |
| 2023 Q4 | -180.8 Million USD | -95.11% |
| 2022 Q4 | -93.44 Million USD | -63.21% |
| 2022 Q3 | -57.25 Million USD | -16.43% |
| 2022 Q2 | -49.17 Million USD | -26.91% |
| 2022 Q1 | -38.75 Million USD | -35.67% |
| 2022 FY | -239.64 Million USD | -139.44% |
| 2021 Q4 | -28.56 Million USD | -7.32% |
| 2021 Q3 | -26.61 Million USD | -12.4% |
| 2021 Q2 | -23.67 Million USD | -11.59% |
| 2021 Q1 | -21.22 Million USD | -2.33% |
| 2021 FY | -100.08 Million USD | -13.97% |
| 2020 FY | -87.81 Million USD | -64.15% |
| 2020 Q4 | -20.73 Million USD | 1.34% |
| 2020 Q3 | -21.01 Million USD | -3.44% |
| 2020 Q2 | -20.32 Million USD | 25.13% |
| 2020 Q1 | -27.14 Million USD | -85.64% |
| 2019 Q1 | -13.67 Million USD | 0.0% |
| 2019 Q4 | -14.62 Million USD | -29.2% |
| 2019 Q2 | -10.66 Million USD | 21.99% |
| 2019 Q3 | -11.31 Million USD | -6.11% |
| 2019 FY | -53.49 Million USD | -81.44% |
| 2018 FY | -29.48 Million USD | -71.05% |
| 2017 FY | -17.23 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -174.776% |
| Alkermes plc | 355.75 Million USD | 213.073% |
| Agenus Inc. | -245.76 Million USD | -63.682% |
| Aptorum Group Limited | -2.82 Million USD | -14141.284% |
| Ardelyx, Inc. | -66.06 Million USD | -508.876% |
| Dyadic International, Inc. | -6.79 Million USD | -5819.628% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -42877.137% |
| Lantern Pharma Inc. | -15.96 Million USD | -2420.221% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -2013.976% |
| Novavax, Inc. | -545.06 Million USD | 26.198% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -590.076% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -445.15% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -2069.006% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -3928.3% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -582.007% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -7.664% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1552.743% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -977.306% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -144.429% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -448.442% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1882.485% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -546.159% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1138.313% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -203.613% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 8.626% |
| AlloVir, Inc. | -190.41 Million USD | -111.254% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -95.964% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1313.841% |
| Bicycle Therapeutics plc | -180.66 Million USD | -122.66% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -124.663% |
| ChromaDex Corporation | -4.93 Million USD | -8046.335% |
| Chimerix, Inc. | -82.09 Million USD | -390.001% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -801.875% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -294.108% |
| CRISPR Therapeutics AG | -153.61 Million USD | -161.875% |
| Precision BioSciences, Inc. | -61.31 Million USD | -556.022% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -149.966% |
| Fortress Biotech, Inc. | -60.63 Million USD | -563.4% |
| Fortress Biotech, Inc. | -60.63 Million USD | -563.4% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -393.094% |
| ImmuCell Corporation | -5.77 Million USD | -6866.13% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -256.111% |
| Immix Biopharma, Inc. | -15.42 Million USD | -2507.706% |
| Incyte Corporation | 597.59 Million USD | 167.314% |
| Innoviva, Inc. | 179.72 Million USD | 323.827% |
| IO Biotech, Inc. | -86.08 Million USD | -367.3% |
| Jaguar Health, Inc. | -41.3 Million USD | -874.01% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -162.933% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 871.304% |
| ContextLogic Inc. | -317 Million USD | -26.898% |
| MiMedx Group, Inc. | 67.43 Million USD | 696.489% |
| MEI Pharma, Inc. | 17.77 Million USD | 2362.718% |
| NextCure, Inc. | -62.72 Million USD | -541.337% |
| Onconetix, Inc. | -37.4 Million USD | -975.299% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -918.937% |
| Opthea Limited | -220.24 Million USD | -82.647% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -686.305% |
| PDS Biotechnology Corporation | -42.94 Million USD | -836.762% |
| Precigen, Inc. | -95.9 Million USD | -319.447% |
| Pharming Group N.V. | -10.54 Million USD | -3713.671% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -99.545% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -1539.025% |
| PureTech Health plc | -65.69 Million USD | -512.305% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -1503.228% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -89.551% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1552.743% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -56.019% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -1376.856% |
| Acelyrin, Inc. | -381.64 Million USD | -5.404% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -3207074.856% |
| Summit Therapeutics Inc. | -614.92 Million USD | 34.583% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1079.631% |
| Senti Biosciences, Inc. | -92.91 Million USD | -332.921% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -284.212% |
| Elevation Oncology, Inc. | -45.7 Million USD | -780.155% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1044.752% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -2977.342% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -5917.442% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1270.022% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -4631.984% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -599.435% |
| Seer, Inc. | -86.27 Million USD | -366.249% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -500.442% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -511.672% |
| ESSA Pharma Inc. | -26.58 Million USD | -1413.283% |
| GlycoMimetics, Inc. | -36.89 Million USD | -990.169% |
| GT Biopharma, Inc. | -7.59 Million USD | -5195.064% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -66.666% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -674.706% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 663.319% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -639.161% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -718.945% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -3943.79% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 29.777% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -11111.427% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -687.861% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -63.792% |
| Aptose Biosciences Inc. | -51.2 Million USD | -685.568% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -309.231% |
| Soligenix, Inc. | -6.14 Million USD | -6450.785% |
| Century Therapeutics, Inc. | -136.67 Million USD | -194.327% |
| Kura Oncology, Inc. | -152.63 Million USD | -163.555% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -350.88% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -3717.29% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 71238.345% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -70597.012% |
| Autolus Therapeutics plc | -208.38 Million USD | -93.042% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -459.495% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -468.212% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -1756.498% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -78.586% |
| GRI Bio, Inc. | -13.03 Million USD | -2985.572% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -9629.312% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -224.188% |
| IGM Biosciences, Inc. | -246.41 Million USD | -63.247% |
| INmune Bio, Inc. | -30 Million USD | -1240.529% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -263.847% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -853.377% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -2420.202% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -2446.796% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -573.982% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -297.626% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -45.682% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -69.096% |
| Verastem, Inc. | -87.36 Million USD | -360.432% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -642.353% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -149.334% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -244.825% |
| Histogen Inc. | -10.62 Million USD | -3687.459% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -2715.657% |
| Surrozen, Inc. | -43.04 Million USD | -834.589% |
| Organovo Holdings, Inc. | -14.67 Million USD | -2641.913% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -7807.68% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -668.579% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -1492.313% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -1393.303% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -4713.472% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -166.251% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -722.192% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1253.292% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -3761.369% |
| Apollomics, Inc. | -172.6 Million USD | -133.061% |
| Amarin Corporation plc | -59.11 Million USD | -580.515% |
| Mesoblast Limited | -87.95 Million USD | -357.349% |
| Turnstone Biologics Corp. | -55.2 Million USD | -628.743% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -173.721% |
| Synaptogenix, Inc. | -6.03 Million USD | -6561.683% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -2381.898% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -415.593% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -8295.468% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -4687.629% |
| Exelixis, Inc. | 207.76 Million USD | 293.616% |
| Better Therapeutics, Inc. | -39.76 Million USD | -911.735% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -179.452% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 23.904% |
| NLS Pharmaceutics AG | -12.17 Million USD | -3204.839% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -5060.77% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1208.225% |
| Gritstone bio, Inc. | -138.49 Million USD | -190.466% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -524.007% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -9956.776% |
| Avid Bioservices, Inc. | -140.75 Million USD | -185.796% |
| Insmed Incorporated | -749.56 Million USD | 46.334% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -2548.315% |
| MediWound Ltd. | -6.71 Million USD | -5889.666% |
| OmniAb, Inc. | -50.61 Million USD | -694.694% |
| Alector, Inc. | -130.39 Million USD | -208.507% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -253.721% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -675.871% |
| Zai Lab Limited | -334.62 Million USD | -20.216% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -24.162% |
| Aura Biosciences, Inc. | -76.4 Million USD | -426.471% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -71.445% |
| Immunic, Inc. | -93.61 Million USD | -329.716% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -196.017% |
| Veracyte, Inc. | -74.4 Million USD | -440.651% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -5140.875% |
| FibroGen, Inc. | -284.23 Million USD | -41.527% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1433.493% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -5645.106% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -2035.998% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 196.971% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -1683.489% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 916.436% |
| TG Therapeutics, Inc. | 12.67 Million USD | 3274.448% |
| Galecto, Inc. | -38.34 Million USD | -948.961% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -2032.227% |
| Fortrea Holdings Inc. | -3.4 Million USD | -11731.353% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -217.635% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -2210.413% |
| XBiotech Inc. | -24.55 Million USD | -1538.091% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -524.007% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -541.777% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -308.699% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -1777.379% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -628.835% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 33.689% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -489.358% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -706447.933% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -77.57% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -1706.515% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -83.09% |
| NexImmune, Inc. | -32.34 Million USD | -1143.696% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -7509.2% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -2763.94% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 110.175% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -1560.815% |
| Scopus BioPharma Inc. | -11.6 Million USD | -3364.875% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -244.412% |
| Ainos, Inc. | -13.77 Million USD | -2821.205% |
| Pluri Inc. | -20.88 Million USD | -1825.823% |
| Prothena Corporation plc | -147.02 Million USD | -173.598% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -253.265% |
| Celularity Inc. | -196.29 Million USD | -104.929% |
| Rallybio Corporation | -74.56 Million USD | -439.491% |
| Cue Biopharma, Inc. | -50.73 Million USD | -692.908% |
| MeiraGTx Holdings plc | -84.02 Million USD | -378.734% |
| Omeros Corporation | -117.81 Million USD | -241.444% |
| Humacyte, Inc. | -110.77 Million USD | -263.135% |
| Immunocore Holdings plc | -55.28 Million USD | -627.596% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -2136.799% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -1654.245% |
| Blueprint Medicines Corporation | -506.98 Million USD | 20.655% |
| CalciMedica, Inc. | -34.35 Million USD | -1070.841% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -494.409% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -184.478% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -142.637% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -42.015% |
| Pulmatrix, Inc. | -14.12 Million USD | -2748.708% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1042.963% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -386.781% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 16.402% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -283.582% |
| Cytokinetics, Incorporated | -526.24 Million USD | 23.559% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1015.392% |
| Nutriband Inc. | -5.48 Million USD | -7233.509% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -895.215% |
| Vor Biopharma Inc. | -117.86 Million USD | -241.3% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 109.25% |
| Evogene Ltd. | -23.87 Million USD | -1584.602% |
| ProKidney Corp. | -35.46 Million USD | -1034.166% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -235.885% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -5027.419% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 37.459% |
| CorMedix Inc. | -46.33 Million USD | -768.09% |
| BioLineRx Ltd. | -60.61 Million USD | -563.652% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -295.371% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -879.56% |
| Atai Life Sciences N.V. | -40.22 Million USD | -900.065% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -398.779% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -432.654% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -37.672% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1343.055% |
| MediciNova, Inc. | -8.57 Million USD | -4593.055% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -226.311% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -4702.125% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1449.157% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -68.145% |
| Biomea Fusion, Inc. | -117.25 Million USD | -243.069% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 35.802% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1265.187% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -162.641% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -92.141% |
| Absci Corporation | -110.56 Million USD | -263.824% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1234.216% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -298.927% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -70.497% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 2956.191% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -108.469% |
| Allakos Inc. | -185.7 Million USD | -116.62% |
| Imunon, Inc. | -19.51 Million USD | -1961.319% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -313.28% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 478.996% |
| BioAtla, Inc. | -123.46 Million USD | -225.822% |
| NLS Pharmaceutics AG | -12.17 Million USD | -3204.839% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -2401.965% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -22.918% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -988.706% |
| XOMA Corporation | -40.83 Million USD | -885.198% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -294.882% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -239.428% |
| aTyr Pharma, Inc. | -50.38 Million USD | -698.321% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -358.794% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -165.069% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -69.208% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1045.437% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -4871.194% |
| Akari Therapeutics, Plc | -10 Million USD | -3919.444% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -597398.7% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 242.853% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -5935.59% |
| UroGen Pharma Ltd. | -102.24 Million USD | -293.437% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -276.678% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -5072.386% |
| Orgenesis Inc. | -55.36 Million USD | -626.623% |
| Entera Bio Ltd. | -8.88 Million USD | -4425.436% |
| GH Research PLC | -35.58 Million USD | -1030.373% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -1830.259% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -419.804% |
| Xencor, Inc. | -126.08 Million USD | -219.038% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -10582.364% |
| Replimune Group, Inc. | -215.79 Million USD | -86.412% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -1791.544% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 16132.921% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -5935.59% |
| Portage Biotech Inc. | -75.33 Million USD | -433.941% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -4702.125% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -316.187% |
| OncoCyte Corporation | -27.78 Million USD | -1347.99% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -2898.134% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -3517.006% |
| Purple Biotech Ltd. | -19.88 Million USD | -1923.471% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -5631.101% |
| scPharmaceuticals Inc. | -54.81 Million USD | -633.928% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -2197.856% |
| HilleVax, Inc. | -123.56 Million USD | -225.547% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -3880.073% |
| Tharimmune, Inc. | -9.31 Million USD | -4216.578% |
| Genprex, Inc. | -30.86 Million USD | -1203.5% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -70.506% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1236.698% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -22473.85% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -7495.636% |
| OKYO Pharma Limited | -16.82 Thousand USD | -2390717.25% |
| Savara Inc. | -54.69 Million USD | -635.431% |
| Curis, Inc. | -47.41 Million USD | -748.43% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1233.712% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -2504.492% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -7123.308% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1249.207% |
| BeiGene, Ltd. | -881.7 Million USD | 54.377% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -1789.105% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 7.815% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -409.488% |
| Erasca, Inc. | -125.04 Million USD | -221.705% |
| bluebird bio, Inc. | -211.91 Million USD | -89.826% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -7944.52% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 339.951% |
| DBV Technologies S.A. | -72.72 Million USD | -453.125% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -7944.52% |
| Moderna, Inc. | -4.71 Billion USD | 91.467% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -901.733% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -6964.735% |
| Molecular Templates, Inc. | -8.12 Million USD | -4851.576% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -566.136% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -261.104% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -197.2% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -739.471% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -184.43% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -109.067% |
| MacroGenics, Inc. | -9.05 Million USD | -4341.002% |
| RenovoRx, Inc. | -10.23 Million USD | -3831.45% |
| Adicet Bio, Inc. | -142.65 Million USD | -181.979% |
| Prime Medicine, Inc. | -198.13 Million USD | -103.028% |
| Aditxt, Inc. | -32.38 Million USD | -1142.296% |
| Adagene Inc. | -18.94 Million USD | -2023.182% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5401.658% |
| Quantum-Si incorporated | -95.96 Million USD | -319.202% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -237.956% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -2659.448% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 403.987% |
| SciSparc Ltd. | -5.12 Million USD | -7753.69% |
| Vericel Corporation | -3.18 Million USD | -12541.923% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -334413.613% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1240.647% |
| Generation Bio Co. | -126.61 Million USD | -217.716% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -451.873% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -387.938% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -53.455% |
| Invivyd, Inc. | -198.64 Million USD | -102.507% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -17.631% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -4530.894% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1863.86% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -3973.992% |
| 2seventy bio, Inc. | -217.57 Million USD | -84.89% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1324.505% |
| Clene Inc. | -49.5 Million USD | -712.593% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -1704.892% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -713.744% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1449.157% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -22.617% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1136.109% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1870.537% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -307.186% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -438.12% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -150.158% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 34.597% |
| Evaxion Biotech A/S | -22.12 Million USD | -1718.151% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -398.249% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -101.065% |
| Trevena, Inc. | -40.28 Million USD | -898.451% |
| Surrozen, Inc. | -43.04 Million USD | -834.589% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -481.864% |
| Cingulate Inc. | -23.53 Million USD | -1609.228% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -5719.821% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -909.197% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -5117.002% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -345.922% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -556.375% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -576.043% |
| Clearmind Medicine Inc. | -11.95 Million USD | -3264.826% |
| Kronos Bio, Inc. | -112.67 Million USD | -257.021% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -481.334% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -15860685.497% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -368.323% |
| Statera Biopharma, Inc. | -174.4 Million USD | -130.646% |
| ImmunityBio, Inc. | -583.19 Million USD | 31.024% |
| Korro Bio, Inc. | -81.17 Million USD | -395.572% |
| Kineta, Inc. | -14.09 Million USD | -2753.153% |
| BioVie Inc. | -32.12 Million USD | -1152.364% |
| Codexis, Inc. | -76.24 Million USD | -427.631% |
| Celularity Inc. | -196.29 Million USD | -104.929% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -87.511% |
| Celcuity Inc. | -63.77 Million USD | -530.717% |
| Virax Biolabs Group Limited | -6.73 Million USD | -5874.067% |
| Cibus, Inc. | -267.62 Million USD | -50.308% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -897.535% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1023.303% |
| IN8bio, Inc. | -30 Million USD | -1240.574% |
| Kodiak Sciences Inc. | -260.49 Million USD | -54.426% |
| Annexon, Inc. | -134.23 Million USD | -199.668% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -243.333% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -556.997% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1175.254% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -9.823% |
| Eyenovia, Inc. | -27.26 Million USD | -1375.605% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1963.119% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -75089.907% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -426.499% |
| Arcellx, Inc. | -70.69 Million USD | -469.056% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -870.696% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -200.611% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1239.235% |
| Moolec Science SA | -51.78 Million USD | -676.742% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -668.108% |
| Geron Corporation | -184.12 Million USD | -118.472% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -858.369% |
| Royalty Pharma plc | 1.13 Billion USD | 135.447% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -195.88% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -4424.009% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -1793.62% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -134.325% |
| Humacyte, Inc. | -110.77 Million USD | -263.135% |
| Structure Therapeutics Inc. | -89.62 Million USD | -348.857% |
| 89bio, Inc. | -142.18 Million USD | -182.909% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -483.332% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -3776.515% |
| Genelux Corporation | -28.29 Million USD | -1321.585% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1284.022% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -127.116% |
| Notable Labs, Ltd. | -11.26 Million USD | -3471.254% |
| Liquidia Corporation | -78.5 Million USD | -412.428% |
| Mustang Bio, Inc. | -51.6 Million USD | -679.555% |
| Immunovant, Inc. | -259.33 Million USD | -55.114% |
| Quantum-Si incorporated | -95.96 Million USD | -319.202% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -452.192% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -1975.569% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -319.071% |
| Acasti Pharma Inc. | -12.85 Million USD | -3029.744% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -1691.204% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -2420.202% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -120.549% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -9251.724% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -3125.87% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1264.03% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -931.769% |
| PepGen Inc. | -78.62 Million USD | -411.62% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1251.292% |
| United Therapeutics Corporation | 984.8 Million USD | 140.847% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -1707.125% |
| Solid Biosciences Inc. | -96.01 Million USD | -318.962% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -8295.468% |
| Immuneering Corporation | -53.47 Million USD | -652.298% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -7807.68% |
| Silo Pharma, Inc. | -3.7 Million USD | -10770.048% |
| Belite Bio, Inc | -31.63 Million USD | -1171.706% |
| XOMA Corporation | -40.83 Million USD | -885.198% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -639.936% |
| Bionomics Limited | -15.49 Billion USD | 97.403% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -378.974% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1279.655% |
| uniQure N.V. | -308.47 Million USD | -30.403% |
| Cassava Sciences, Inc. | -97.21 Million USD | -313.782% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5401.658% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -225.906% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1178.009% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -4804.664% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1283.879% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -75089.907% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1433.493% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -2340.194% |
| Altimmune, Inc. | -88.44 Million USD | -354.81% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -165.375% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1279.655% |
| Compugen Ltd. | -18.75 Million USD | -2044.961% |
| Peak Bio, Inc. | -1259.26 USD | -31944534.15% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -773.561% |
| Benitec Biopharma Inc. | -21.75 Million USD | -1749.414% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -18.736% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -384.927% |
| Zura Bio Limited | -60.36 Million USD | -566.445% |
| PolyPid Ltd. | -23.86 Million USD | -1585.59% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -2456.992% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -384.927% |
| Instil Bio, Inc. | -156.08 Million USD | -157.719% |
| argenx SE | -295.05 Million USD | -36.337% |
| Immunome, Inc. | -106.8 Million USD | -276.632% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -846.642% |
| Verona Pharma plc | -54.36 Million USD | -639.881% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -302.6% |
| Shattuck Labs, Inc. | -87.29 Million USD | -360.796% |
| CervoMed Inc. | -2.17 Million USD | -18421.617% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -222.714% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -2920.922% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -823.582% |
| Moolec Science SA | -51.78 Million USD | -676.742% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -2326249.07% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -197.716% |
| AnaptysBio, Inc. | -163.61 Million USD | -145.855% |
| Design Therapeutics, Inc. | -66.86 Million USD | -501.636% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -394.099% |
| NeurAxis, Inc. | -14.62 Million USD | -2650.22% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -961.892% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1081.953% |
| Achilles Therapeutics plc | -69.66 Million USD | -477.429% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -302.6% |
| 180 Life Sciences Corp. | -19.93 Million USD | -1917.877% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 13469.693% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -15860685.497% |
| Nutriband Inc. | -5.48 Million USD | -7233.509% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -299.482% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -727.589% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -421.807% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1084.18% |
| MoonLake Immunotherapeutics | -36 Million USD | -1017.18% |
| Palisade Bio, Inc. | -12.3 Million USD | -3170.455% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -854.957% |
| Beam Therapeutics Inc. | -132.52 Million USD | -203.535% |
| Neurogene Inc. | -36.31 Million USD | -1007.652% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -146.162% |
| AEON Biopharma, Inc. | -52.55 Million USD | -665.405% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -309.861% |
| Sesen Bio, Inc. | -19.88 Million USD | -1923.064% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -461.95% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -3114.554% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 9.407% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -260.563% |
| Athira Pharma, Inc. | -117.67 Million USD | -241.854% |
| Vaccinex, Inc. | -20.25 Million USD | -1886.401% |
| HCW Biologics Inc. | -24.99 Million USD | -1509.432% |
| XOMA Corporation | -40.83 Million USD | -885.198% |
| Nektar Therapeutics | -276.05 Million USD | -45.719% |
| Arvinas, Inc. | -367.3 Million USD | -9.52% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -597398.7% |
| Merus N.V. | -154.93 Million USD | -159.629% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -312.885% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1181.714% |
| Rezolute, Inc. | -68.45 Million USD | -487.601% |
| Clene Inc. | -49.5 Million USD | -712.593% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2508.142% |
| BeyondSpring Inc. | -21.02 Million USD | -1813.184% |
| Synlogic, Inc. | -57.28 Million USD | -602.256% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -3280.103% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -3615.74% |
| Peak Bio, Inc. | -1259.26 USD | -31944534.15% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -976.499% |
| Krystal Biotech, Inc. | 10.93 Million USD | 3779.711% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -181.11% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -23.735% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -8609.007% |
| MannKind Corporation | -11.93 Million USD | -3269.626% |
| Ikena Oncology, Inc. | -68.16 Million USD | -490.127% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -1814.185% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -332.856% |
| Gossamer Bio, Inc. | -179.81 Million USD | -123.709% |
| CohBar, Inc. | -11.96 Million USD | -3262.832% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1459.896% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1234.216% |
| Legend Biotech Corporation | -518.25 Million USD | 22.381% |
| Mural Oncology plc | -207.44 Million USD | -93.913% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -224.107% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -2099.41% |
| Disc Medicine, Inc. | -76.42 Million USD | -426.326% |
| Champions Oncology, Inc. | -7.27 Million USD | -5428.67% |
| REGENXBIO Inc. | -263.49 Million USD | -52.666% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -3690.287% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -746.787% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -959.055% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -301.611% |
| Vaxart, Inc. | -82.46 Million USD | -387.802% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 120624.444% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -971.495% |
| Cellectis S.A. | -101.05 Million USD | -298.051% |
| Longeveron Inc. | -21.41 Million USD | -1778.606% |
| Repare Therapeutics Inc. | -93.79 Million USD | -328.873% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 24.947% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -465.226% |
| Revolution Medicines, Inc. | -436.36 Million USD | 7.815% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -6021.838% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1205.042% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -480.194% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -521.433% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -4000.153% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 111.114% |
| Denali Therapeutics Inc. | -145.22 Million USD | -176.997% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -334413.613% |
| Veru Inc. | -93.15 Million USD | -331.835% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -1388.276% |
| Cingulate Inc. | -23.53 Million USD | -1609.228% |
| Passage Bio, Inc. | -102.06 Million USD | -294.139% |
| Context Therapeutics Inc. | -23.96 Million USD | -1578.611% |
| Exicure, Inc. | -16.91 Million USD | -2278.302% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -112.933% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -965.21% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -6081.742% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -117.82% |
| Nuvalent, Inc. | -126.21 Million USD | -218.705% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -3725.401% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -363.019% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1217.005% |
| OmniAb, Inc. | -50.61 Million USD | -694.694% |
| Anew Medical, Inc. | 1.34 Million USD | 29983.257% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -2407.111% |
| Lipocine Inc. | -16.35 Million USD | -2360.029% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -505.877% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -531.749% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -853.377% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -738.631% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -1928.471% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 25.711% |
| Ocugen, Inc. | -63.07 Million USD | -537.728% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -320.2% |
| Q32 Bio Inc. | -112.96 Million USD | -256.111% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -2239.844% |
| Alumis Inc. Common Stock | -154.99 Million USD | -159.538% |
| Equillium, Inc. | -13.33 Million USD | -2916.618% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -566.378% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -4935.982% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -2033.898% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -580.86% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -251.241% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -2088.851% |
| Dominari Holdings Inc. | -22.88 Million USD | -1658.002% |
| Edesa Biotech, Inc. | -8.37 Million USD | -4703.512% |
| vTv Therapeutics Inc. | -20.25 Million USD | -1886.499% |
| Bio-Techne Corporation | 168.1 Million USD | 339.294% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -14.252% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 412.19% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -230.181% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -960.297% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -257.119% |
| Nkarta, Inc. | -117.5 Million USD | -242.351% |
| BioCardia, Inc. | -11.57 Million USD | -3376.502% |
| Iterum Therapeutics plc | -38.37 Million USD | -948.359% |